Cytek Biosciences, Inc. CTKB Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenue, net by Geography | ||||||
| APAC | $39.94M+4.3% | $41.08M+14.8% | $39.4M+16.6% | $37.19M+17.6% | $38.31M+29.1% | |
| China | $18.8M— | $20.5M— | —— | —— | —— | |
| EMEA | $55.08M-6.3% | $55.88M-10.4% | $52.47M-20.3% | $57.32M-6.8% | $58.78M+3.4% | |
| Other | $8.05M-20.9% | $9.28M-4.7% | $10.82M+70.9% | $10.24M+48.7% | $10.17M+35.0% | |
| United States | $101.12M+12.6% | $95.26M+2.8% | $94.14M-1.2% | $91.29M-6.6% | $89.79M-15.9% | |
| Total by Geography | ||||||
| APAC | $38.26M+3.7% | $38.02M+3.2% | $37.72M+2.4% | $37.4M+4.9% | $36.89M+8.9% | |
| EMEA | $1.78M-2.6% | $1.76M-3.0% | $1.77M+3.9% | $1.88M— | $1.83M— | |
| United States | $34.84M+3.4% | $32.46M-5.0% | $32.71M-5.9% | $33.38M-5.7% | $33.7M-3.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cytek Biosciences, Inc. break its business down?
- Cytek Biosciences, Inc. (CTKB) reports total revenue, net by geography across 5 parts — APAC, China, EMEA, Other and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Cytek Biosciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cytek Biosciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
